Xerostomia Therapeutics Market 2018 -2026 | Focuses on Top Companies, Methodology, Key Players, Trends, Opportunities and Regions
Xerostomia is also defined as dry mouth condition causing due to absent or reduced saliva. In general, xerostomia is not considered as a disorder, but it is a condition with symptom associated with various medical situations such as a side effect of a radioactivity to the head and neck generally during chemotherapy or a side effect of a number of medications. It may or may not be associated with decreased salivary gland function.
Xerostomia is a common problem majorly observed in geriatric population affecting around 20% of the individuals. However, xerostomia does not act to be age-related disorder itself as xerostomia is generally caused as a side effect.
Xerostomia Therapeutics Market Size is anticipated to reach over USD 822.14 million by 2026 according to a new research published by Polaris Market Research.
Request Sample for more Professional and Technical insights @
Some major key players in Xerostomia Therapeutics Market include: -
- Eisai Inc.
- Colgate-Palmolive Company
- Dentaid
- EUSA Pharma
- Forward Science
- GlaxoSmithKline plc
- Mission Pharmacal Company
- OraHealth Inc.
- OraPharma Inc.
- Parnell Pharmaceuticals Inc.
- Saliwell Ltd.
- Sun Pharmaceutical Industries
Growth Factors: -
The rise in favourable reimbursement scenario for xerostomia products and growing awareness about related with ailments are the major factors contributing the Xerostomia Therapeutics Market growth.
Moreover, growing occurrence of xerostomia and related diseases such as hypertension, Parkinson’s disease, Sjogren’s syndrome, and diabetes has an affirmative influence on the market. According to the industry reports, approximately 25 million individuals in the U.S. experience dry mouth.
Moreover, according to Sjogren Syndrome Foundation of America, approximately 4 million Americans are suffering Sjogren’s syndrome. Rising resourcefulness for the growth of awareness regarding xerostomia other factors expected to drive the Xerostomia Therapeutics Market growth. For instance, Sjogren Syndrome Foundation of America conducts wakefulness programs to support people suffering the syndrome in North America.
In addition, the foundation introduced the ‘5-Year Breakthrough Goal’ in 2012 with an object to cure the xerostomia as well as decrease the time required to analyze it. Moreover, key players are focusing on acquiring developing establishments and conduct lineups to increase consciousness regarding xerostomia, further enhancing the market growth significantly.
For 'Queries' related to this research report, Make an Enquiry @
On the basis of product, the Xerostomia Therapeutics Market is segmented into Artificial Saliva, Dentifrices, Salivary Stimulants, Saliva Substitutes, Drugs, and Salivary Pen. On the basis of products, dentifrices segment is estimated to dominate the market. The dominance is primarily due to affordability, availability, effectiveness, higher adoption amongst the users.
On the basis of the distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies. In 2017, the hospital pharmacy is anticipated to dominate the market. The dominance of hospital pharmacy is majorly due to the availability of limited branded drugs, safety & efficacy, safety, and low pricing of products.
Asia Pacific is anticipated to make a dominating growth for market during the forecast period. growing healthcare spending, the rise in inventiveness for growing awareness, and increasing occurrence of ailments such as Parkinson’s disease, diabetes, cancer, and HIV causing dry mouth conditions and factors estimated to bolster the market in the Asia Pacific.
Partial TOC of Xerostomia Therapeutics Market: -
- Industry snapshot
- Ecosystem analysis
- Market Dynamics
- Industry analysis - Porter's five force
- Degree of competition
- Market PEST Analysis
- Market Value Chain Analysis
- Industry Trends
- Competitive Ranking Analysis
About Us:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.
Contact Us:
Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: [email protected]
Web: www.polarismarketresearch.com
Posted by
polarismarketresearch
on Tuesday November 20 2018, 2:47 AM EDT.
All trademarks acknowledged.
Filed under Uncategorized.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
